Tel: 732-484-9848
Fax: 888-484-5008
Email: [email protected]
   
Building blocks
Intermediates
Bioactive molecules
Product Pathways
All Targets
Anti-infection
Antibody-drug conjugate....
Apoptosis
Autophagy
Biochemical Reagent
Cell Cycle/DNA Damage
Cytoskeleton
Epigenetics
GPCR/G protein
Immunology/Inflammation
JAK/STAT Signaling
MAPK/ERK Pathway
Membrane Transporter/Io....
Metabolic Enzyme/Protease
Neuronal Signaling
NF-κB
Others
PI3K/Akt/mTOR
Protein Tyrosine Kinase....
Stem Cells/Wnt
TGF-beta/Smad
Vitamin D Related
Research Area
Cancer
Cardiovascular Disease
Endocrinology
Infection
Metabolic Disease
Neurological Disease
Others
Inflammation/Immunology
Product Type
All Products
New Products
Featured Products
Home   »   Product Pathways  »  Akt  »  BAY1125976

Products are for research use only. Not for human use. We do not sell to patients.


CS-6212 BAY1125976


(BAY-1125976;BAY 1125976)
Structure Price and Availability of    BAY1125976
United States
Size Price Stock
2mg $110 In-stock Inquiry
5mg $180 In-stock
10mg $280 In-stock
50mg $580 In-stock
100mg $980 In-stock
200 mg Get quote
500 mg Get quote
 Distributor In Japan:  フナコシ株式会社 www.funakoshi.co.jp    電話番号:81-3-5684-1620   
 FAX番号:81-3-5684-1775
Inquiry for price and availability only. Please place your order via our email or fax.
Contact us for competitive discounts on bulk quantities .
  • Data Sheet
  • Introduction
  • References
  • Related Products

BAY1125976  M.Wt:  383.45
BAY1125976  Formula: C23H21N5O
BAY1125976  Solubility: ≤10.33 mg/mL in DMSO
BAY1125976  Purity: >98%
BAY1125976  Storage:  Please store the product under the recommended conditions in the Certificate of Analysis.
CAS: 1402608-02-9

View current batch:

BAY1125976 is a selective allosteric AKT1/2 inhibitor; inhibits AKT1 and AKT 2 activity with IC50 values of 5.2 nM and 18 nM at 10 μM ATP, respectively. IC50&Target: 5.2 nM (AKT1, at 10 μM ATP), 18 nM (AKT2, at 10 μM ATP)[1] InVitro: BAY 1125976 is equally potent against AKT1 (IC50=5.2 nM at 10 μM ATP and 44 nM at 2 mM ATP)and AKT2(IC50=18 nM at 10 μM ATP and 36 nM at 2 mM ATP) isoforms and up to 86 fold less potent against AKT3(IC50=427 nM at 10 μM ATP). It inhibits the AKT1 and AKT2 by binding into an allosteric binding pocket formed by kinase and PH domain. It inhibits cell proliferation in a broad panel of human cancer cell lines, particularly in breast and prostate cancer cell lines expressing estrogen or androgen receptors. It effectively blocks AKT signaling by inhibiting the phosphorylation of AKT and the downstream effectors, including eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1), glycogen synthase kinase 3 beta (GSK3s), proline-rich Akt substrate 40 kDa (PRAS40), S6 ribosomal protein (S6RP), and 70 kDa ribosomal protein S6 kinase 1 (70S6K)[1]. InVivo: BAY 1125976 targets tumors displaying activation of the PI3K/AKT/mTOR pathway. BAY 1125976 exhibited strong in vivo efficacy in both cell line and patient-derived xenograft models such as the KPL4 breast cancer model (PIK3CAH1074R mutant), the MCF7 and HBCx-2 breast cancer models, and the AKTE17K mutant driven prostate cancer (LAPC-4) and anal cancer (AXF 984) models[1].

Akt  |  
Keywords: buy BAY1125976 | BAY1125976 Supplier | purchase BAY1125976 | BAY1125976 cost | BAY1125976 manufacturer | order BAY1125976 | BAY1125976 distributor | BAY1125976 structure,chemscene
buy 1402608-02-9 | 1402608-02-9 Supplier | purchase 1402608-02-9 | 1402608-02-9 cost | 1402608-02-9 manufacturer | order 1402608-02-9 | 1402608-02-9 distributor | 1402608-02-9 structure,chemscene


CHEMSCENE, LLC
Tel: 732-484-9848
Fax: 888-484-5008
Email:  [email protected]
Address: 11 Deer Park Drive, Suite 102D Monmouth Junction, NJ 08852.
Products are for research use only. Not for human use. We do not sell to patients. Sitemap | Inhibitor © Copyright 2012. All Rights Reserved.